WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

A BRIEF REVIEW ON ITRACONAZOLE AND TURBINAFINE

Prachi R. Chaudhari*, Dr. J. K. Patil, V. H. Jain and Dr. S. P. Pawar

ABSTRACT

Itraconazole has broader spectrum of activity. Itraconazole is over 99% protein bound and has virtually no penetration into cerebrospinal fluid. Terbinafine, sold under the brand name Lamisil, among others is an antifungal medication used to treat pityriasis versicolor, fungal nail infection, and ringworm including jock itch and athlete’s foot. Terbinafine is increasingly used in combination with itraconazole antifungal to treat resistant or refractory mycoses due to synergistic in vitro antifungal activity. Due to its broad antifungal spectrum, interest in terbinafine has expanded to include its use in range of cutaneous and subcutaneous mycosis, such as sporotrycosis. As well as in combination with itraconazole to treat resistant or refreactory invasive fungal infection. :- terbinafine inhibits ergosterol synthesis by inhibiting the fungal squalene monooxygenase(squalene 2,3 – epoxidase) an enzyme that is part of the fungal cell wall synthesis pathway. Itraconazole inhibit fungal cytochrome P450 3A dependent enzyme decreases ergosterol synthesis and inhibits cell membrane formation.

Keywords: : Itraconazole, terbinafine, onychomycosis, Lamisil, sporonax.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More